cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Revolution Medicines Inc
3 own
4 watching
Current Price
$24.53
$-1.64
(-6.27%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,640.44M
52-Week High
52-Week High
35.50000
52-Week Low
52-Week Low
17.47000
Average Volume
Average Volume
3.6M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,640.44M
icon52-Week High35.50000
icon52-Week Low17.47000
iconAverage Volume3.6M
iconDividend Yield--
iconP/E Ratio--
What does the Revolution Medicines Inc do?
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, high-value frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways.
Read More
How much money does Revolution Medicines Inc make?
News & Events about Revolution Medicines Inc.
Ticker Report
6 months ago
Revolution Medicines, Inc. (NASDAQ:RVMD Get Rating) Director Thilo Schroeder purchased 100,000 shares of the firms stock in a transaction on Friday, March 10th. The stock was acquired at an average price of $20.46 per share, for a total transaction of $2,046,000.00. Following the ...
Globe Newswire
7 months ago
REWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced the pricing of its underwritten public offering of 13,636,364 shares of common stock at a ...
Market News Video
8 months ago
In trading on Thursday, shares of Revolution Medicines Inc (RVMD) touched a new 52-week high of 28.06/share. Thats a 99.29% rise, or 13.98 per share from the 52-week low of 14.08 set back on 05/12/2022...
Globe Newswire
9 months ago
Findings Published in the Journal of Medicinal Chemistry Demonstrate Compounds Exceptional Selectivity for mTORC1 over mTORC2 Tumor Regressions Observed During Combination Treatment with a Bi-Steric mTORC1-Selective Inhibitor and a KRASG12C-Selective Inhibitor in Preclinical Lung Cancer Model that ...
Frequently Asked Questions
Frequently Asked Questions
What is Revolution Medicines Inc share price today?
plus_minus_icon
Can Indians buy Revolution Medicines Inc shares?
plus_minus_icon
How can I buy Revolution Medicines Inc shares from India?
plus_minus_icon
Can Fractional shares of Revolution Medicines Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Revolution Medicines Inc stocks?
plus_minus_icon
What is today’s traded volume of Revolution Medicines Inc?
plus_minus_icon
What is today’s market capitalisation of Revolution Medicines Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Revolution Medicines Inc?
plus_minus_icon
What percentage is Revolution Medicines Inc down from its 52-Week High?
plus_minus_icon
What percentage is Revolution Medicines Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$24.53
$-1.64
(-6.27%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
ZENTALIS PHARMACEUTICALS INC
ZENTALIS PHARMACEUTICALS INC
$19.31
$-0.55 (-2.77 %)
TARSUS PHARMACEUTICALS INC
TARSUS PHARMACEUTICALS INC
$17.59
$0.15 (0.86 %)
KYMERA THERAPEUTICS INC
KYMERA THERAPEUTICS INC
$15.50
$1.93 (14.22 %)
KEROS THERAPEUTICS INC
KEROS THERAPEUTICS INC
$30.85
$0.03 (0.10 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
ZENTALIS PHARMACEUTICALS INC
ZENTALIS PHARMACEUTICALS INC
$19.31
$-0.55 (-2.77 %)
TARSUS PHARMACEUTICALS INC
TARSUS PHARMACEUTICALS INC
$17.59
$0.15 (0.86 %)
KYMERA THERAPEUTICS INC
KYMERA THERAPEUTICS INC
$15.50
$1.93 (14.22 %)
KEROS THERAPEUTICS INC
KEROS THERAPEUTICS INC
$30.85
$0.03 (0.10 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00